|
|
|
|
| LEADER |
03456nam a22004935i 4500 |
| 001 |
9752 |
| 003 |
DE-He213 |
| 005 |
20130725194434.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2010 gw | s |||| 0|eng d |
| 020 |
# |
# |
|a 9783540782810
|9 978-3-540-78281-0
|
| 024 |
7 |
# |
|a 10.1007/978-3-540-78281-0
|2 doi
|
| 050 |
# |
4 |
|a RC254-282
|
| 072 |
# |
7 |
|a MJCL
|2 bicssc
|
| 072 |
# |
7 |
|a MED062000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.994
|2 23
|
| 100 |
1 |
# |
|a Liersch, R<U+00fc>diger.
|e editor.
|
| 245 |
1 |
0 |
|a Angiogenesis Inhibition
|c edited by R<U+00fc>diger Liersch, Wolfgang E. Berdel, Torsten Kessler.
|h [electronic resource] /
|
| 264 |
# |
1 |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg,
|c 2010.
|
| 300 |
# |
# |
|a XVII, 231p. 50 illus., 25 illus. in color.
|b online resource.
|
| 336 |
# |
# |
|a text
|b txt
|2 rdacontent
|
| 337 |
# |
# |
|a computer
|b c
|2 rdamedia
|
| 338 |
# |
# |
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
# |
# |
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
# |
|a Recent Results in Cancer Research,
|v 180
|x 0080-0015 ;
|
| 505 |
0 |
# |
|a Introduction. Angiopoietins -- HIF-1a and cancer therapy -- Chemokines -- Platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy -- Vascular integrins: therapeutic and imaging targets of tumor angiogenesis. PDGF and vessel maturation -- Lymphangiogenesis in cancer: current perspectives -- Therapeutic compounds in clinical studies of Phase III trials and beyond -- Metronomic chemotherapy <U+0013> principles and lessons learned from applications in the treatment of metastatic prostate cancer -- Targeting inflammatory cells to improve anti-VEGF therapies in oncology -- Antibody-based vascular tumor targeting. Caveolae and cancer.
|
| 520 |
# |
# |
|a Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials on therapeutic compounds are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in research and treatment in this exciting field.
|
| 650 |
# |
0 |
|a Medicine.
|
| 650 |
# |
0 |
|a Oncology.
|
| 650 |
# |
0 |
|a Hematology.
|
| 650 |
1 |
4 |
|a Medicine & Public Health.
|
| 650 |
2 |
4 |
|a Oncology.
|
| 650 |
2 |
4 |
|a Hematology.
|
| 650 |
2 |
4 |
|a Cancer Research.
|
| 700 |
1 |
# |
|a Berdel, Wolfgang E.
|e editor.
|
| 700 |
1 |
# |
|a Kessler, Torsten.
|e editor.
|
| 710 |
2 |
# |
|a SpringerLink (Online service)
|
| 773 |
0 |
# |
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783540782803
|
| 830 |
# |
0 |
|a Recent Results in Cancer Research,
|v 180
|x 0080-0015 ;
|
| 856 |
4 |
0 |
|u https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-3-540-78281-0
|
| 912 |
# |
# |
|a ZDB-2-SME
|
| 950 |
# |
# |
|a Medicine (Springer-11650)
|